Survival of HIV-1 in Syringes: Effects of Temperature during Storage

References

• Abdala N., Stephens P. C., Griffith B. P., Heimer R. Survival of HIV-1 in syringes. J. Acquired Immune Deficiency Syndrome Hum. Retroviral. 1999; 20: 73–80
   PubMedGoogle Scholar
• Agar M. Ripping and Running. A Formal Ethnography of Urban Heroin Addicts. Seminar Press, New York, NY 1973
   Google Scholar
• Bourgois P. The moral economics of homeless heroin addicts. Confronting ethnography. HIV risk, and everyday violence in San Francisco shooting encampments. Substance Use Misuse 1998; 33: 2323–2351
   PubMed Web of Science ®Google Scholar
• Centers for Disease Control and Prevention (CDC). Surveillance Rep. 1998; 10(2)
   Google Scholar
• Chaisson R., Bacchetti P., Osmond D., Brodie B., Sande M., Moss A. Cocaine use and HIV infection in intravenous drug users in San Francisco. JAMA 1989; 261: 561–565
   PubMed Web of Science ®Google Scholar
• Chaisson R., Moss A., Onishi R., Osmond D., Carlson J. Human immunodeficiency virus infection in heterosexual intravenous drug users in San Francisco. Am. J. Public Health 1987; 77: 169–172
   PubMed Web of Science ®Google Scholar
• Chitwood D. D., Griffin D. K., Comerford M., Page J. B., Trapido E. J., Lai S., McCoy C. B. Risk factors for HIV-1 seroconversion among drug injectors: A case-control study. Am. J. Public Health 1995; 85: 1538–1542
   PubMed Web of Science ®Google Scholar
• Clatts M. C., Heimer R., Abdala N., Sotheran J. L., Goldsamt L. A., Anderson K. T., Gallo T. M., Hoffer L. D., Luciano P. A., Kyriakides T. Illicit drug injection and HIV-1 transmission: Heating drug solutions may inactivate HIV-1. J. Acquired Immune Deficiency Syndrome 1999; 22: 194–199
   PubMed Web of Science ®Google Scholar
• Friedman S. R., Jose B., Deren S., Des Jarlais D. C., Neaigus A., National Aids Research Consortium. Risk factors for human immunodeficiency virus seroprevalence cities. Am. J. Epidemiol. 1995; 142: 864–874
   PubMed Web of Science ®Google Scholar
• Gaughwin M. D., Gowans E., All R., Burell C. Bloody needles: The volume of blood transferred in simulations of needlestick injuries and shared use of syringes for injection of intravenous drugs. AIDS 1991; 5: 1025–1027
   PubMed Web of Science ®Google Scholar
• Grund J. -P. C. Drug Use as a Social Ritual: Functionality. Symbolism, and Determinants of Self-Regulation. Addiction Research Institute. Erasmus Universitiet, RotterdamThe Netherlands 1993
   Google Scholar
• Grund J. -P., Stern L. S. Residual blood in syringes: Size and type of syringe are important. AIDS 1991; 5: 1532–1533
   PubMed Web of Science ®Google Scholar
• Hoffman P. N., Larkin D. P., Samuel D. Needlestick and needleshare—The difference. J. Infect. Dis. 1989; 160: 545
   PubMed Web of Science ®Google Scholar
• Hollinger F. B. ACTG Virology Manual for HIV Laboratories. Division of Aids, Niaid, NIH, Bethesda, MD 1993
   Google Scholar
• Holmberg S. D. The estimated prevalence and incidence of HIV in 96 large US metropolitan areas. Am. J. Public Health 1996; 86: 642–654
   PubMed Web of Science ®Google Scholar
• Marmor M., Des Jarlais D. C., Cohen H., Friedman S. R., Beatrice S. T., Dubin N., El-Sadr W., Mildvan D., Yancovitz S., Mathur U. Risk factors for infection with human immunodeficiency virus among intravenous drug abusers in New York City. AIDS 1987; 1: 39–44
   PubMed Web of Science ®Google Scholar
• Martin L. S., McDougal, Loskoski S. L. Disinfection and inactivation of the human T lymphotropic virus type III/lymphadenopathy-associated virus. J. Infect. Dis. 1985; 152: 400–403
   PubMed Web of Science ®Google Scholar
• Moss A. R., Vranizan K., Gorter R., Bacchetti P., Watters J., Osmond D. HIV seroconversion in intravenous drug users in San Francisco, 1985–1990. AIDS 1994; 8: 223–231
   PubMed Web of Science ®Google Scholar
• Myers L. E., McQuay L. J., Hollinger F. B. Dilution assay statistics. J. Clin. Microbiol. 1994; 32: 732–739
   PubMed Web of Science ®Google Scholar
• Needle R. H., Coyle S. L., Normand J., Lambert E., Cesari H. HIV prevention with drug-using populations—Current status and future prospects. Public Health Rep. 1998; 113(Suppl. 1)4–15
   PubMedGoogle Scholar
• Schoenbaum E. E., Hartel D., Selwyn P. A., Klein R. S., Davenny K., Rogers M., Feiner C., Friedland G. Risk factors for human immunodeficiency virus infection in intravenous drug users. New Engl. J. Med. 1989; 321: 874–879
   PubMed Web of Science ®Google Scholar
• Shapiro M. F., Morton S. C., McCaffrey D. F., Sentirfitt J. W., Fleishman J. A., Perlman J. F., Athey L. A., Keesey J. W., Goldman D. P., Berry S. H., Bozzette S. A. Variations in the care of HIV-infected adults in the United States: Results from the HIV Cost and Services Utilization Study. JAMA 1999; 281: 2305–2315
   PubMed Web of Science ®Google Scholar
• Strathdee S. A., Palepu A., Cornelisse P. G., Yip B., O'shaughnessy M. V., Montaner J. S., Schechter M. T., Hogg R. S. Barriers to use of free antiretroviral therapy in injection drug users. JAMA 1998; 280: 547–549
   PubMed Web of Science ®Google Scholar
• Vlahov D., Munoz A., Anthony J. C., Cohn S., Celento D. D., Nelson K. E. Association of drug injection patterns with antibody to human immunodeficiency virus type 1 among intravenous drug users in Baltimore, Maryland. Am. J. Epidemiol. 1990; 132: 847–856
   PubMed Web of Science ®Google Scholar
• Wiebel W. W., Jimenez A., Johnson W., Ouellet L., Jevanovic B. T. L., Murray J., O'brien M. U. Risk behavior and HIV seroincidence among out-of-treatment injection drug users: A four-year prospective study. J. Acquired Immune Deficiency Syndrome Hum. Retroviral. 1996; 12: 282–289
   PubMedGoogle Scholar
• Zule W. A., Desmond D. P. An ethnographic comparison of HIV risk behaviors among heroin and methamphetamine injectors. Am. J. Drug Alcohol Abuse 1999; 25: 1–12
   PubMed Web of Science ®Google Scholar